المؤلفون: de Oca, RM, Alavi, AS, Vitali, N, Bhattacharya, S, Blackwell, C, Patel, K, Seestaller-Wehr, L, Kaczynski, H, Shi, H, Dobrzynski, E, Obert, L, Tsvetkov, L, Cooper, DC, Jackson, H, Bojczuk, P, Forveille, S, Kepp, O, Sauvat, A, Kroemer, G, Creighton-Gutteridge, M, Yang, JS, Hopson, C, Yanamandra, N, Shelton, C, Mayes, P, Opalinska, J, Barnette, M, Srinivasan, R, Smothers, J, Hoos, A

المصدر: Molecular cancer therapeutics. 20(10):1941-1955

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:148065125

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Montes de Oca R; Experimental Medicine Unit, Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania. maria-del-rocio.x.montes-de-oca-ruiz@gsk.com., Alavi AS; Immuno-Oncology and Combinations RU, Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania., Vitali N; Immuno-Oncology and Combinations RU, Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania., Bhattacharya S; Immuno-Oncology and Combinations RU, Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania., Blackwell C; Immuno-Oncology and Combinations RU, Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania., Patel K; Immuno-Oncology and Combinations RU, Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania., Seestaller-Wehr L; Immuno-Oncology and Combinations RU, Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania., Kaczynski H; Immuno-Oncology and Combinations RU, Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania., Shi H; Immuno-Oncology and Combinations RU, Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania., Dobrzynski E; Bioanalysis, Immunogenicity and Biomarkers, GlaxoSmithKline, Collegeville, Pennsylvania., Obert L; Translational Medicine and Comparative Pathobiology, GlaxoSmithKline, Collegeville, Pennsylvania., Tsvetkov L; Immuno-Oncology and Combinations RU, Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania., Cooper DC; Research Statistics, GlaxoSmithKline, Collegeville, Pennsylvania., Jackson H; Immuno-Oncology and Combinations RU, Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania., Bojczuk P; Immuno-Oncology and Combinations RU, Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania., Forveille S; Equipe labellisée par la Ligue contre le cancer, Université de Paris, Sorbonne Université, INSERM U1138, Centre de Recherche des Cordeliers, Paris, France.; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Villejuif, France., Kepp O; Equipe labellisée par la Ligue contre le cancer, Université de Paris, Sorbonne Université, INSERM U1138, Centre de Recherche des Cordeliers, Paris, France.; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Villejuif, France., Sauvat A; Equipe labellisée par la Ligue contre le cancer, Université de Paris, Sorbonne Université, INSERM U1138, Centre de Recherche des Cordeliers, Paris, France.; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Villejuif, France., Kroemer G; Equipe labellisée par la Ligue contre le cancer, Université de Paris, Sorbonne Université, INSERM U1138, Centre de Recherche des Cordeliers, Paris, France.; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Villejuif, France.; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France.; Suzhou Institute for Systems Medicine, Chinese Academy of Medical Sciences, Suzhou, P.R. China.; Karolinska Institute, Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden., Creighton-Gutteridge M; Cell Therapy RU, Oncology R&D, GlaxoSmithKline, Hertfordshire, United Kingdom., Yang J; Immuno-Oncology and Combinations RU, Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania., Hopson C; Immuno-Oncology and Combinations RU, Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania., Yanamandra N; Immuno-Oncology and Combinations RU, Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania., Shelton C; Immuno-Oncology and Combinations RU, Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania., Mayes P; Immuno-Oncology and Combinations RU, Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania., Opalinska J; Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania., Barnette M; Immuno-Oncology and Combinations RU, Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania., Srinivasan R; Experimental Medicine Unit, Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania., Smothers J; Immuno-Oncology and Combinations RU, Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania., Hoos A; Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania.

المصدر: Molecular cancer therapeutics [Mol Cancer Ther] 2021 Oct; Vol. 20 (10), pp. 1941-1955. Date of Electronic Publication: 2021 Jul 12.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE

مواضيع طبية MeSH: Immunogenic Cell Death*, Antibodies, Monoclonal, Humanized/*pharmacology , B-Cell Maturation Antigen/*antagonists & inhibitors , CD8-Positive T-Lymphocytes/*immunology , Immunoconjugates/*pharmacology , Lymphoma/*drug therapy , Multiple Myeloma/*drug therapy, Animals ; Antibodies, Monoclonal/chemistry ; Apoptosis ; B-Cell Maturation Antigen/immunology ; Cell Proliferation ; Female ; Humans ; Lymphoma/immunology ; Lymphoma/metabolism ; Lymphoma/pathology ; Mice ; Mice, Inbred C57BL ; Multiple Myeloma/immunology ; Multiple Myeloma/metabolism ; Multiple Myeloma/pathology ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays